Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
Stopped early · Phase 2
Conditions studied: Acute Heart Failure, Decompensated Heart Failure
In brief
To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.
Key facts
- Study ID
- NCT03170219
- Run by
- Adrian Hernandez
- People needed
- 11
- Starts
- 2018-04-27
- Expected to finish
- 2018-09-20
- Last updated by the study team
- 2019-01-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Emory University Hospital — Atlanta, Georgia, United States
- Northwestern University — Chicago, Illinois, United States
- Johns Hopkins Hospital — Baltimore, Maryland, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University — St Louis, Missouri, United States
- Saint Louis University Hospital — St Louis, Missouri, United States
- Stony Brook University Medical Center — Stony Brook, New York, United States
- Duke University — Durham, North Carolina, United States
- University Hospitals- Case Medical Center — Cleveland, Ohio, United States
- Metro Health System — Cleveland, Ohio, United States
- Cleveland Clinic — Cleveland, Ohio, United States
- University of Pennsylvaina — Philadelphia, Pennsylvania, United States
- University of Vermont — Burlington, Vermont, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.